½ÃÀ庸°í¼­
»óǰÄÚµå
1292432

īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°(º´¿ø, Áø´Ü ½ÇÇè½Ç), ¼¼°è ¿¹Ãø(-2032³â)

Cart-based Conventional Breast Ultrasound Systems Market - By End-use (Hospitals, Diagnostics Laboratories) - Global Forecast to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀº À¯¹æ¾Ï À¯º´·ü Áõ°¡¸¦ ¹è°æÀ¸·Î 2023³âºÎÅÍ 2032³â±îÁö Å« ÆøÀÇ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛÀº À¯¹æÀÇ ºñħ½ÀÀû ¿µ»ó Áø´Ü¿¡ »ç¿ëµÇ´Â ÀÇ·á¿ë ¿µ»ó Áø´Ü ÀåºñÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÄÄÇ»ÅÍ, ¸ð´ÏÅÍ, º¯È¯±â ¹× Á¦¾î ÀåÄ¡°¡ ÀåÂøµÈ īƮ·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, À¯¹æ¾ÏÀ» Æ÷ÇÔÇÑ À¯¹æ Á¶Á÷ÀÇ ½Ç½Ã°£ À̹ÌÁö¸¦ Á¦°øÇÏ¿© À¯¹æ¾ÏÀ» Æ÷ÇÔÇÑ À¯¹æ ÀÌ»óÀ» °¨ÁöÇϰí Áø´ÜÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. À¯¹æ¾Ï ¹ß»ý·üÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó Á¤È®Çϰí È¿À²ÀûÀÎ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¿ä±¸°¡ Á¡Á¡ ´õ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛÀº À¯¹æ¾Ï °ËÁøÀ» À§ÇÑ ºñħ½ÀÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ¿µ»ó ¼Ö·ç¼ÇÀ» Á¦°øÇϱ⠶§¹®¿¡ µµÀÔÀÌ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÃÊÀ½ÆÄ ¿µ»óÁø´Ü ºÐ¾ß´Â ÃÖ±Ù ¸î ³â µ¿¾È Å« ¹ßÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛÀº À̹ÌÁö ǰÁú Çâ»ó, °íÇØ»óµµÈ­, ¿¤¶ó½ºÅä±×·¡ÇÇ ¹× ÀÚµ¿ À¯¹æ º¼·ý ½ºÄµ°ú °°Àº °í±Þ ±â´ÉÀ» ÅëÇØ ´õ¿í Á¤±³ÇØÁ³½À´Ï´Ù. ¶ÇÇÑ, À¯¹æ ÃÔ¿µ¼ú°ú °°Àº ´Ù¸¥ ¿µ»ó ÃÔ¿µ ¹æ½Ä°ú ÅëÇÕÇÏ¿© À¯¹æÀÇ ÀÌ»óÀ» º¸´Ù Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. īƮ ±â¹Ý ½Ã½ºÅÛÀº È޴뼺°ú ÅëÇÕ¼ºÀÌ Çâ»óµÇ¾î ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ¸Å·ÂÀûÀ̸ç, ±× °á°ú äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀº ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â Áø´Ü ½ÇÇè½Ç ºÎ¹®ÀÌ 2022³â »ó´çÇÑ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2032³â±îÁö »ó´çÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤È®Çϰí È¿À²ÀûÀÎ À¯¹æ ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Áø´Ü ½ÇÇè½ÇÀº Áø´Ü ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ Ä«Æ®½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç½ÇÀº À¯¹æ¾Ï °ËÁø, Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖÀ¸¸ç, ÷´Ü ¿µ»ó ±â¼úÀ» äÅÃÇÏ´Â Áß¿äÇÑ ¸ñÇ¥°¡ µÇ°í ÀÖ½À´Ï´Ù. ´õ ¸¹Àº °Ë»ç½ÇÀÌ ¿öÅ©Ç÷ο쿡 ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» µµÀÔÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Ãß¼¼´Â ÇâÈÄ ¸î ³â µ¿¾È Ȱ¹ßÇÏ°Ô ÁøÇàµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¸ÅÃâ°ú ¼öÀÍÀÇ Áõ°¡·Î À̾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â À¯·´ÀÌ Àü ¼¼°è īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¹æ¾Ï À¯º´·üÀÇ Áõ°¡¿Í Á¶±â ¹ß°ß ¹× °ËÁø ÇÁ·Î±×·¥¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ Áö¿ª¿¡¼­´Â ÷´Ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¹æ¾Ï °ËÁøÀ» Áö¿øÇÏ´Â À¯¸®ÇÑ º¸Çè ȯ±Þ Á¤Ã¥ ¹× Á¤ºÎÀÇ ³ë·Âµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯·´¿¡¼­´Â ±âÁ¸ ±â¾÷ÀÇ Á¸Àç, źźÇÑ ÀÇ·á ÀÎÇÁ¶ó, ÀÇ·áºñ Áõ°¡°¡ Àüü »ê¾÷ Àü¸ÁÀ» Çâ»ó½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ¾÷°è ÀλçÀÌÆ®

  • ¾÷°è ¼¼ºÐÈ­
  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°èÀÇ À¯¹æ¾Ï À¯º´·ü Áõ°¡
      • ±âÁ¸ À¯¹æ¿ë ÃÊÀ½ÆÄ Áø´Ü ÀåºñÀÇ ±â¼úÀû Áøº¸ »ó½Â
      • À¯¹æ¾Ï¿¡ ´ëÇÑ ÀÎ½Ä È®»ê°ú Á¤ºÎÀÇ Àû±ØÀûÀÎ ´ëó
      • À¯¹æ ÃÊÀ½ÆÄ °Ë»ç¿¡ ´ëÇÑ Áø·á º¸¼ö Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè°ú °úÁ¦
      • ½Ã½ºÅÛÀÇ °íºñ¿ë
      • °³¹ßµµ»ó±¹À̳ª Àú°³¹ß Áö¿ªÀÇ ¼÷·ÃÀÚ³ª ÈÆ·ÃµÈ ÀÎÀç ºÎÁ·
  • ¼ºÀå °¡´É¼º ºÐ¼®
    • ÃÖÁ¾ ¿ëµµº°
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
    • À¯·´
  • ±â¼ú »óȲ
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï »óȲ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®, 2021³â
  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ½ÃÀå Á¡À¯À², 2021³â
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·«Àû Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀ塤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ, ÃÖÁ¾ ¿ëµµº°
  • º´¿ø
  • Áø´Ü ½ÇÇè½Ç
  • ±âŸ

Á¦6Àå īƮ½Ä ±âÁ¸ À¯¹æ ÃÊÀ½ÆÄ Áø´Ü ½Ã½ºÅÛ ½ÃÀ塤¿¹Ãø : Áö¿ªº°

  • Áö¿ªº° ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ½ºÀ§½º
    • ³×´ú¶õµå
    • üÄÚ
    • Æú¶õµå
    • ³ë¸£¿þÀÌ
    • º§±â¿¡
    • Çɶõµå
    • Çë°¡¸®
    • µ§¸¶Å©
    • ¾ÆÀÏ·£µå
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ´ºÁú·£µå
    • ´ë¸¸
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • UAE
    • À̽º¶ó¿¤

Á¦7Àå ±â¾÷ °³¿ä

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Canon Medical Systems
  • Samsung Medison
  • Hitachi Healthcare
  • Esaote
  • Fukuda Denshi
  • Analogic Corporation
  • Fujifilm SonoSite
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Fukuda Denshi
ksm 23.06.28

Cart-based Conventional Breast Ultrasound Systems Market is set to depict significant growth from 2023 to 2032, driven by the rising prevalence of breast cancer.

Cart-based conventional breast ultrasound systems are medical imaging devices used for non-invasive imaging of the breast. These systems consist of a cart with a computer, monitor, transducer, and controls, which provide real-time images of breast tissue, helping detect and diagnose breast abnormalities, including breast cancer. As the incidences of breast cancer continue to rise, there is a growing need for accurate and efficient diagnostic tools. Cart-based conventional breast ultrasound systems provide a non-invasive and cost-effective imaging solution for breast cancer screening, leading to increased adoption and market growth.

The ultrasound imaging field has witnessed significant advancements in recent years. Cart-based conventional breast ultrasound systems have become more sophisticated, with improved image quality, higher resolution, and advanced features such as elastography and automated breast volume scanning. Moreover, integration with other imaging modalities, such as mammography, allows for a more comprehensive evaluation of breast abnormalities. The improved portability and integration capabilities of cart-based systems make them attractive to healthcare providers, thereby stimulating their adoption rate.

The cart-based conventional breast ultrasound systems market is segmented based on end-use and region.

Regarding end-use, the diagnostics laboratories segment held a sizable revenue share in 2022 and could grow noticeably through 2032. To suffice the increasing demand for accurate and efficient breast imaging solutions, diagnostics laboratories are investing in cart-based conventional breast ultrasound systems to enhance their diagnostic capabilities. These laboratories play a crucial role in breast cancer screening, diagnosis, and monitoring, making them a key target for the adoption of advanced imaging technologies. As more laboratories incorporate these systems into their workflow, the trend is expected to flourish in the coming years, translating into increased sales and revenue.

Regionally, Europe is poised to hold a dominant share in the global cart-based conventional breast ultrasound systems market. The increasing prevalence of breast cancer and the emphasis on early detection and screening programs have led to a higher demand for advanced imaging technologies in the region. Favorable reimbursement policies and government initiatives supporting breast cancer screening have also facilitated market growth. Additionally, the presence of established market players, robust healthcare infrastructure, and increasing healthcare expenditure in Europe will augment the overall industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Unpaid sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Cart-based conventional breast ultrasound systems market industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 End-use trends

Chapter 3 Cart-based Conventional Breast Ultrasound Systems Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry ecosystem analysis
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of breast cancer worldwide
      • 3.3.1.2 Rising technological advancements in conventional breast ultrasound systems
      • 3.3.1.3 Rising awareness and favorable government initiatives regarding breast cancer
      • 3.3.1.4 Increased reimbursement for breast ultrasound
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of systems
      • 3.3.2.2 Lack of skilled or trained personnel in the developing and underdeveloped region
  • 3.4 Growth potential analysis
    • 3.4.1 By end-use
  • 3.5 COVID- 19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Technology landscape
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive landscape

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Competitive dashboard
  • 4.4 Company market share, 2021
  • 4.5 Competitive analysis of major market players
  • 4.6 Competitive positioning matrix
  • 4.7 Strategic outlook matrix

Chapter 5 Cart-based Conventional Breast Ultrasound Systems Market and Forecast, By End-use (USD Million)

  • 5.1 Key trends, by end-use
  • 5.2 Hospitals
  • 5.3 Diagnostic laboratories
  • 5.4 Others

Chapter 6 Cart-based Conventional Breast Ultrasound Systems Market and Forecast, By Region (USD Million)

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 UK
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy
    • 6.3.6 Switzerland
    • 6.3.7 The Netherlands
    • 6.3.8 Czech Republic
    • 6.3.9 Poland
    • 6.3.10 Norway
    • 6.3.11 Belgium
    • 6.3.12 Finland
    • 6.3.13 Hungary
    • 6.3.14 Denmark
    • 6.3.15 Ireland
    • 6.3.16 Sweden
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Australia
    • 6.4.5 South Korea
    • 6.4.6 New Zealand
    • 6.4.7 Taiwan
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
    • 6.5.3 Argentina
  • 6.6 Middle East & Africa
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia
    • 6.6.3 UAE
    • 6.6.4 Israel

Chapter 7 Company Profiles

  • 7.1 GE Healthcare
  • 7.2 Philips Healthcare
  • 7.3 Siemens Healthineers
  • 7.4 Canon Medical Systems
  • 7.5 Samsung Medison
  • 7.6 Hitachi Healthcare
  • 7.7 Esaote
  • 7.8 Fukuda Denshi
  • 7.9 Analogic Corporation
  • 7.10 Fujifilm SonoSite
  • 7.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • 7.12 Fukuda Denshi
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦